2003
DOI: 10.1097/00132578-200307000-00027
|View full text |Cite
|
Sign up to set email alerts
|

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

16
1,297
3
24

Year Published

2003
2003
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 889 publications
(1,340 citation statements)
references
References 2 publications
16
1,297
3
24
Order By: Relevance
“…Recent guidelines for high blood pressure management, stressed the importance of preventive strategies like lifestyle and dietary modifications (Chobanian et al, 2003). In this sense, Miron et al (2004) observed that the drug Captopril demonstrated potent antihypertensive properties due to its ability to inhibit the angiotensin-converting enzyme, whereas allicin decreased serum cholesterol and triglyceride levels.…”
Section: Bioactivity Perspectives and Applications Of Allium Sulfur mentioning
confidence: 99%
“…Recent guidelines for high blood pressure management, stressed the importance of preventive strategies like lifestyle and dietary modifications (Chobanian et al, 2003). In this sense, Miron et al (2004) observed that the drug Captopril demonstrated potent antihypertensive properties due to its ability to inhibit the angiotensin-converting enzyme, whereas allicin decreased serum cholesterol and triglyceride levels.…”
Section: Bioactivity Perspectives and Applications Of Allium Sulfur mentioning
confidence: 99%
“…140 mmHg and/or mean diastolic blood pressure (DBP) ! 90 mmHg (Chobanian et al, 2003) or current anti-hypertensive medication. The exclusion criteria were persons with secondary hypertension (hypertension due to secondary causes such as renovascular disease, renal failure, pheochromocytoma, aldosteronism or other causes of secondary hypertension), diabetes or under lipid-lowering drugs.…”
Section: Patientsmentioning
confidence: 99%
“…183,185 Other drugs may be specifically indicated based on medical circumstances (such as ACE inhibitors in congestive heart failure). 267 It is widely recognized that individual responses to different antihypertensive medications are highly variable. The field of pharmacogenomics promises to provide tools to help identify individuals who may respond better to particular medications, but specific, clinically useful examples are few.…”
Section: Implications For the Management Of Hypertensionmentioning
confidence: 99%
“…Although a few instances of differential response based on genotype are noted above, none are sufficiently consistent to warrant changing recommended treatment approaches that are based on clinical trial data. 267,270 Summarizing the contribution of genetics to current treatment choice for the vast majority of hypertensives, there is no genetic test that contributes in a meaningful way to choice of antihypertensive drugs or diet intervention. This remains true currently despite enticing leads regarding potentially greater salt responsiveness for variants of genes such as ␣-adducin, ENaC, or some of the genes of the RAS.…”
Section: Implications For the Management Of Hypertensionmentioning
confidence: 99%
See 1 more Smart Citation